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Summary Pyomyositis occurs most commonly in patients with various immunosuppressive
diseases. However, the association of pyomyositis with an underlying hematological malignancy
has not been reviewed. We present herein a relevant case and also review the available literature
regarding the association of non-tropical pyomyositis and hematological malignancies. The case
patient, a 46-year old female, had non-tropical pyomyositis of the iliopsoas and obturator muscles
due to Staphylococcus aureus and underlying Hodgkin’s disease. Forty-four patients with pyo-
myositis and an associated hematological malignant disease have been reported in the literature.
The most common types of hematological oncology diseases found were acute lymphocytic
leukemia (present in 11/44 patients (25%)) and multiple myeloma (7/44 patients (15.9%)).
Staphylococcus aureus was the most common cause of pyomyositis (26 out of 44 patients
(59.1%)). The muscles of the thigh were most commonly affected (18/44 patients (40.9%)).
Medical therapy with antibiotics and surgical drainage were employed in 25/44 (56.8%) of
the patients. Thirty out of 44 (68.2%) of the patients had a successful outcome. Death occurred
in 5/44 (11.4%) patients. In cases of pyomyositis, the physician should consider an underlying
hematological malignancy.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.* Corresponding author. Tel.: +30 694 611 0000;
ax: +30 210 683 9605.
E-mail address: m.falagas@aibs.gr (M.E. Falagas).
201-9712/$32.00 # 2007 International Society for Infectious Diseases.
oi:10.1016/j.ijid.2007.06.005Introduction
Pyomyositis is classified into two main types, tropical and
non-tropical. The disease may occur in immunocompromised
patients mainly due to infection with the human immuno-Published by Elsevier Ltd. All rights reserved.
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nancies and other forms of neoplasia. The usual microbial
cause of pyomyositis is Staphylococcus aureus, which is
responsible for 70% of the cases in HIV positive patients
and in 64% of cases in non-HIV-infected individuals.1 Other
pathogens that may cause pyomyositis are various coagulase-
negative Staphylococcus species, various streptococcal spe-
cies, Gram-negative bacteria, as well as anaerobic bacteria,
including Bacteroides fragilis, and fungi. The disease may
affect practically all the skeletal muscles of the body, includ-
ing muscles in the extremities and the trunk.2 A particular
form of the disease that is difficult to manage is the one that
is located in the retroperitoneal space involving the muscles
of the area, specifically the iliopsoas muscles and the obtura-
tor muscles.
Combined medical and surgical intervention is the pre-
ferred method of management. Antimicrobial treatment
should include antibiotics with spectrum mainly against S.
aureus. However, obtaining specimens from the affected
muscles for microbiological cultures may considerably help
the clinician in the selection of the appropriate antimicrobial
treatment.3 This is because, occasionally, pyomyositis is
caused by bacteria other than S. aureus and also because
this pathogen may be resistant to anti-staphylococcal peni-
cillins (methicillin-resistant Staphylococcus aureus — MRSA).
Case report
A 46-year-old female patient complained of mild fever,
weakness, left extremity swelling, and fullness of the left
inguinal area that became progressively worse over a period
of 1 month. She was seen by her primary care physician who
did not find any abnormal findings in the physical examination
except for lymph node enlargement in the inguinal area. He
recommended biopsy of the enlarged lymph nodes, which
was unrevealing. She developed lymphorrhea for about 2
weeks after the procedure.
Two months after the start of her initial symptoms, she
presented at our hospital with higher fever (up to 38 8C) and
more weakness. She was admitted to the hospital for further
management. Physical examination showed left lower extre-
mity swelling and lymph node enlargement in the left inguinalFigure 1 Edema and erythema of the left lower limb.area (Figure 1). Routine laboratory investigation revealed an
increased white blood cell count (WBC: 20.07  109/l, 81.9%
neutrophils), C-reactive protein (CRP: 9.1 mg/dl (normal:
0—0.5)), and erythrocyte sedimentation rate (ESR: 87 mm
1st hour). She was found to have MRSA bacteremia. Imaging
of her body with computed tomography (CT) scans revealed
abscesses in the left iliopsoas and obturator muscle (pyomyo-
sitis; Figure 2) and lymphadenopathy of the inguinal, med-
iastinal, and preaortic areas. No other source of active
infection was identified, except the findings from the retro-
peritoneal space. A magnetic resonance imaging (MRI) of the
spine and a colonoscopy that included visualization of the
terminal ileum were negative. She received intravenous anti-
microbial treatment with linezolid (600 mg every 12 hours),
clindamycin (600 mg every 8 hours), and rifampin (600 mg
every morning and 300 mg every night) for 4 weeks that
improved her condition. Specifically the fever decreased
and she felt better. In addition, the laboratory indices of
inflammation also improved.
A surgical consultation was obtained; the patient under-
went laparoscopic surgery with incision of the peritoneum for
access to the retroperitoneal space. Histological examination
of the excised tissue was again unrevealing. The patient
subsequently underwent an open surgery, during which more
tissue was excised from the retroperitoneal space. No find-
ings of active infection in the retroperitoneal space were
found macroscopically during the operation. In addition,
cultures of specimens of the excised tissue did not grow
any microorganisms. Histological examination of the excised
tissue revealed the diagnosis of Hodgkin’s lymphoma (nodular
sclerosis); Reed—Sternberg cells were visualized as well as
Hodgkinmonocytes surrounded by T-cell rosettes. Finally, the
presence of Hodgkin lymphomawas verified by immunochem-
ical testing (CD15+, CD30+). In addition the resected tissue
contained many non-neoplastic inflammatory cells with the
presence of many neutrophils, eosinophils, plasma cells, and
histiocytes. Bone marrow examination was normal.
Literature review and discussion
In Table 1 we present the available evidence from publica-
tions regarding patients with pyomyositis associated withFigure 2 Abscesses in the left iliopsoas muscle on computed
tomography imaging.
122
M
.E
.
Fala
gas
e
t
al.
Table 1 Reports of patients with pyomyositis associated with hematological malignancies
First author Year of
publication
[ref.]
Patient’s
age and
sex
Hematological
malignancy
Pathogen causing
pyomyositis
Site of muscle
involvement
Medical treatment Surgical treatment Outcome
of infection
Kao 2006 [4] 10/F ALL Staphylococcus
aureus (blood)
Thigh (R) Vancomycin, ceftazidime Drainage Successful
Karmazyn 2006 [5] NR ALL NR NR NR NR NR
Yu 2004 [6] 52/F NHL MRSA (pus) Thigh (R) Antibiotics (not specified) Incision and drainage NR
12/F ALL Staphylococcus
aureus (pus)
Thighs
bilaterally
Antibiotics (not specified) Incision and drainage NR
77/F Myeloproliferative
disease
Aeromonas
hydrophila (pus)
Left lower leg Antibiotics (not specified) Incision and drainage NR
50/F Myeloproliferative
disease
Negative cultures Thigh (R) Antibiotics (not specified) US guided aspiration NR
5/M Diffuse large
B-cell lymphoma
Negative cultures Forearm (R) Antibiotics (not specified) Not performed NR
36/M ALL Staphylococcus
aureus (pus)
Thigh (L) Antibiotics (not specified) US guided aspiration NR
Chang 2005 [7] 15/F AML (M2) Acremonium sp (pus) Calf area
bilaterally
Amphotericin-B, G-CSF Drainage Successful
Hayashi 2003 [8] 40/M CML MRSA (pus) Femoris (R) Imipenem—cilastatin,
amikacin, minocycline
Incision and drainage Successful
46/M MDS (RAEB-t) MRSA (pus) Forearm (R) Vancomycin, teicoplanin,
amikacin
Drainage Successful
71/M MDS (RAEB-t) MRSA (sputum) Vastus lateralis (L) Vancomycin Not performed due
to thrombocytopenia
Death
Tsai 2003 [9] 35/M MDS (RAEB-t) Stenotrophomonas
maltophilia (blood,
fasciotomy wound tissue)
Soleus (L) Ceftazidime changed
to imipenem
Fasciotomy with
debridement and
external drainage
Successful
Torres 2001 [10] 21/M AML Nocardia asteroides (pus) Thighs bilaterally Trimethoprim—
sulfamethoxazole
Not performed Successful
Demir 2000 [11] 42/M NHL Staphylococcus
aureus (pus)
Vastus lateralis (R),
biceps femoris (L)
Ampicillin—sulbactam Drainage and
debridement
bilaterally
Successful
Hossain 2000 [12] 48/M AML Staphylococcus aureus Deltoid, quadriceps Antibiotics
(not specified)
Not performed Successful
Matsuno 1998 [13] 68/M MM Bacteroides fragilis (pus) Right arm and thigh Imipenem—cilastatin Incision and drainage Successful
Cone 1997 [14] 22/M Lymphoblastic
lymphoma
Staphylococcus aureus NR Nafcillin NR Successful
69/M Plasma cell
leukemia
Staphylococcus aureus NR Cefazolin NR Successful
62/M MDS Klebsiella pneumoniae NR Ceftazidime NR Successful
75/M MM Aeromonas hydrophila NR Cefazolin NR Successful
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del Giglio 1997 [15] 27/F ALL Mycobacterium
tuberculosis (biopsy)
Leg (L) Isoniazid, rifampin,
ethambutol, ofloxacin
Open surgical
drainage
Successful
74/F AML Mycobacterium
tuberculosis (pus)
Gluteal and
quadriceps muscles (L)
Triple antituberculous
therapy
NR Death
Corden 1996 [16] 9/M ALL Staphylococcus
aureus (pus, blood)
Thighs bilaterally Nafcillin, cephapirin,
cefonicid
Incision and
drainage
Successful
10/M ALL Staphylococcus
aureus (pus)
Thighs bilaterally,
gluteal (L)
Cephapirin Incision and
drainage
Successful
Katagiri 1996 [17] 68/F MM Bacteroides
fragilis (pus)
Femoral quadriceps (R),
brachial biceps (R)
Imipenem—cilastatin,
clindamycin
Incision and
drainage
Successful
Gordon 1995 [18] 70/M CLL Staphylococcus
aureus (blood)
Iliacus, gluteus maximus,
biceps femoris (R)
Antibiotics (not
specified)
Incision and drainage Successful
68/M CLL Staphylococcus
aureus (pus)
Vastus medialis (L) Antibiotics (not
specified)
Incision and
drainage
Successful
63/M CLL Staphylococcus
aureus (pus)
Gluteus maximus (L) Antibiotics (not
specified)
Drainage under CT
guidance
Successful
Audran 1993 [19] 78/M Myelomonocytic
leukemia
Salmonella sp (blood) Adductor Antibiotics (not
specified)
Not performed Successful
Hoyle 1993 [20] 44/M MM Staphylococcus
aureus (pus, blood, BAL)
Multiple sites in the
limbs
Vancomycin,
flucloxacillin
NR Successful
Christin 1992 [21] 30/M AMML Staphylococcus
aureus (pus, blood)
Multiple sites Penicillinase-resistant
synthetic penicillin,
aminoglycoside
NR Successful
19/M ALL Staphylococcus
aureus (pus)
Multiple Penicillinase-resistant
synthetic penicillin,
aminoglycoside,
cephalosporin 1st
generation
Incision and
drainage
Successful
79/M Hodgkin’s disease Staphylococcus
aureus (pus)
Right paraspinal NR NR NR
NR Hodgkin’s disease Clostridium
septicum (pus)
Gluteus (L) NR NR NR
66/M MDS Staphylococcus
aureus (pus)
Thigh (L) Penicillinase-resistant
synthetic penicillin,
aminoglycoside
NR Successful
Prallet 1992 [22] 45/F MM Staphylococcus
aureus (pus, blood)
Infraspinatus,
coracobrachialis, deltoid
Pefloxacin, fusidic acid Incision and
drainage
Successful
Korten 1992 [23] 64/M MM Pseudomonas
aeruginosa (pus,
subcutaneous nodule)
Left calf muscles Ceftazidime,
ciprofloxacin
Not performed Successful
Bonafede 1992 [24] 66/M Preleukemia Staphylococcus
aureus (pus)
Thigh NR NR Successful
70/M MDS Staphylococcus
aureus (pus)
Psoas NR NR Secondary
Escherichia coli
infection/death
124 M.E. Falagas et al.
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.hematological malignancies.4—27 While HIV is a well-known
predisposing factor for the development of pyomyositis, a
number of other diseases have been reported in association
with pyomyositis as well. These ailments include diabetes
mellitus, trauma, rheumatologic diseases, liver cirrhosis,
renal failure, respiratory diseases, organ transplantation,
and conditions requiring immunosuppressive agents (includ-
ing corticosteroids).3
Relatively little attention has been paid to the association
of hematological diseases with pyomyositis. Both malignant
and non-malignant hematological diseases have been
reported in association with pyomyositis. Our patient proved
to have Hodgkin’s disease in association with pyomyositis. By
reviewing the literature, we found 44 other reported patients
with hematological neoplastic diseases associated with pyo-
myositis: 11 patients with acute lymphocytic leukemia, four
with acute myelogenous leukemia, two patients with mye-
lomonocytic leukemia (one of them with the acute form),
two patients with Hodgkin’s disease, four patients with non-
Hodgkin lymphoma, three patients with chronic lymphocytic
leukemia, one patient with chronic myelogenous leukemia,
seven patients with multiple myeloma, one patient with
plasma cell leukemia, seven patients with myelodysplastic
syndromes (three of themwith refractory anemia with excess
blasts in transformation), and two patients with myelopro-
liferative disease.4—27 Non-malignant hematological diseases
associated with pyomyositis are sickle cell anemia and aplas-
tic anemia.28,29
Diagnosis of pyomyositis is facilitated by MRI or CTscanning
of the affected area and by aspiration of fluid for microbio-
logical testing under ultrasound or CT guidance. Reviewing the
44 patients retrieved from the literature, S. aureuswas found
tobe themostcommoncauseofpyomyositis (grew inculture in
26 out of 44 patients (59.1%)) and was the causative pathogen
of the pyomyositis in our patient as well. Bacteroides fragilis,
Mycobacterium tuberculosis, and Aeromonas hydrophilawere
next in frequency and were present in two patients each. The
following pathogens were the cause of the pyomyositis in one
patient with a hematological malignancy each: Serratia mar-
cescens, Salmonella sp, Klebsiella pneumoniae, Pseudomonas
aeruginosa, Stenotrophomonas maltophilia, Clostridium sep-
ticum,Nocardia asteroides, Acremonium sp, and Fusarium sp.
The pathogenwas recovered from cultures of the pus (drained
or aspirated) in 30/44 patients (in seven of these 30 patients
the pathogen grew additionally in cultures taken from at least
one other site). In 4/44 patients the microorganism grew in
blood cultures; in one of them additionally, a fasciotomy
wound tissue culture was positive. Two patients had negative
blood and pus cultures and no data exist for six patients
regarding the site of growth of the microbial pathogen, while
one pathogen was found on histological examination. The
muscles of the thigh were most commonly affected (18/44
patients (40.9%)). Unilateral muscle involvement was more
common (33/44 patients (75%)) in pyomyositis associated
with a hematological malignancy than bilateral involvement
(in 6/44 patients (16%)).
Treatment of pyomyositis includes the appropriate anti-
biotics against the offending pathogen and surgical incision
and drainage. Treatment of the underlying disease, if any,
should also be promptly provided. The outcome of the infec-
tion is usually successful if treated promptly. In 25/44
patients surgical drainage was performed and in two of these
Pyomyositis associated with hematological malignancy 125patients debridement was performed additionally. Drainage
with radiological guidance was performed in 3/44 patients.
Drainage was not performed in six patients (in one of them
due to thrombocytopenia). No data exist about drainage for
13/44 patients. Our patient was treated with intravenous
antibiotics for the pyomyositis with a successful outcome of
the infection. The outcome of the infection was successful in
30/44 patients. Five out of the 44 patients with pyomyositis
died, one of them due to secondary sepsis due to Escherichia
coli and one patient due tomassive gastrointestinal bleeding.
No data exist on the outcome of 9/44 patients.
In conclusion, we have presented a case of a middle-aged
woman with retroperitoneal pyomyositis and underlying
Hodgkin’s disease and a review of the literature regarding
published cases of pyomyositis in patients with hematological
malignancies. Our experience adds to the relevant literature
and suggests that once a diagnosis of non-tropical pyomyo-
sitis is established one has to consider an underlying hema-
tological malignancy.
Conflict of interest: No conflict of interest to declare.
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